Morton Cure Paralysis Fund Grant

The Morton Cure Paralysis Fund (MCPF) is dedicated to advancing therapies for paralysis linked to spinal cord injuries and central nervous system disorders. By funding innovative research, MCPF helps scientists obtain crucial proof-of-concept data to secure larger grants from major organizations. The fund emphasizes collaboration and dissemination of scientific findings. Applications are accepted biannually, with deadlines on April 30 and September 30, and decisions typically made within 180 days.

The Morton Cure Paralysis Fund (MCPF) is committed to developing effective therapies (cures) for paralysis associated with spinal cord injury and other disorders of the central nervous system (CNS).
MCPF supports cutting-edge SCI therapies enabling researchers to gather proof-of-concept data needed to pursue multimillion-dollar grants from larger financiers such as the National Institutes of Health (NIH), the Christopher & Dana Reeve Foundation, and the National Science Foundation. Further, all scientific learning as a result of our funding must be broadly communicated to the rest of the scientific community.
Qualified scientists at capable institutions will be considered for grant application. MCPF has a biannual application cycle with grant deadlines on April 30 and September 30. Decisions will be made within 180 days of the grant submission deadline. (Many are done faster.)